恩捷股份(002812.SZ)擬斥58億元在重慶投建16條高性能鋰離子電池微孔隔膜生產線及39條塗布線
格隆匯1月8日丨恩捷股份(002812.SZ)宣佈,公司擬由控股子公司上海恩捷於2021年1月8日與長壽經濟技術開發區管理委員會在重慶市簽訂《長壽經濟技術開發區項目投資協議書》,上海恩捷擬在重慶市長壽經濟技術開發區投資建設16條高性能鋰離子電池微孔隔膜生產線及39條塗布線項目,項目投資總額為58億元,項目資金通過自有資金與自籌資金等方式解決。
項目分兩期進行建設,第一期項目擬規劃建設4條鋰離子電池隔膜生產線及12條塗布線;第二期項目擬規劃建設12條鋰離子電池隔膜生產線及27條塗布線,主要開展鋰離子電池隔膜基膜和塗布膜製造、銷售等。同時,公司擬授權管理層辦理相關投資事項,並簽署相關決議、協議等法律文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.